Intermolecular Inc (NASDAQ:IMI) was upgraded by stock analysts at ValuEngine from a “strong sell” rating to a “sell” rating in a note issued to investors on Monday.

Intermolecular (NASDAQ IMI) traded up 1.05% on Monday, hitting $0.96. 29,900 shares of the stock traded hands. The firm has a 50-day moving average price of $0.94 and a 200-day moving average price of $0.95. Intermolecular has a 12 month low of $0.78 and a 12 month high of $1.36. The company’s market capitalization is $47.58 million.

ILLEGAL ACTIVITY WARNING: “Intermolecular Inc (IMI) Upgraded to Sell at ValuEngine” was first published by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another publication, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be viewed at https://www.americanbankingnews.com/2017/08/07/intermolecular-inc-imi-upgraded-to-sell-at-valuengine.html.

In other news, major shareholder Lloyd I. Miller III bought 80,000 shares of the business’s stock in a transaction dated Thursday, June 22nd. The stock was purchased at an average cost of $0.88 per share, with a total value of $70,400.00. Following the acquisition, the insider now directly owns 70,368 shares in the company, valued at $61,923.84. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Over the last ninety days, insiders have bought 165,599 shares of company stock valued at $143,226. Insiders own 15.20% of the company’s stock.

A hedge fund recently raised its stake in Intermolecular stock. Symmetry Peak Management LLC increased its stake in Intermolecular Inc (NASDAQ:IMI) by 0.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,023,323 shares of the semiconductor company’s stock after buying an additional 3,182 shares during the period. Symmetry Peak Management LLC owned about 2.07% of Intermolecular worth $952,000 at the end of the most recent quarter. 38.87% of the stock is currently owned by hedge funds and other institutional investors.

About Intermolecular

Intermolecular, Inc provides thin film solutions. The Company’s high productivity combinatorial (HPC) platform, which consists of its tempus processing tools, its automated characterization methods, and its Informatics analysis software, is purpose-built for research and development (R&D) using combinatorial process systems.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Intermolecular Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intermolecular Inc and related companies with MarketBeat.com's FREE daily email newsletter.